JP2007513610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513610A5 JP2007513610A5 JP2006540415A JP2006540415A JP2007513610A5 JP 2007513610 A5 JP2007513610 A5 JP 2007513610A5 JP 2006540415 A JP2006540415 A JP 2006540415A JP 2006540415 A JP2006540415 A JP 2006540415A JP 2007513610 A5 JP2007513610 A5 JP 2007513610A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- effective
- human gamma
- chimerized
- thp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03292873A EP1532984A1 (en) | 2003-11-19 | 2003-11-19 | Use of anti CD44 antibodies for eradicating stem cells in acute myeloid leukemia |
| PCT/EP2004/014157 WO2005049082A2 (en) | 2003-11-19 | 2004-11-19 | Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513610A JP2007513610A (ja) | 2007-05-31 |
| JP2007513610A5 true JP2007513610A5 (enExample) | 2007-11-22 |
Family
ID=34429570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006540415A Pending JP2007513610A (ja) | 2003-11-19 | 2004-11-19 | キメラ抗ｃｄ４４抗体およびそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20050147606A1 (enExample) |
| EP (3) | EP1532984A1 (enExample) |
| JP (1) | JP2007513610A (enExample) |
| KR (1) | KR20060126659A (enExample) |
| CN (1) | CN1898268A (enExample) |
| AT (1) | ATE480565T1 (enExample) |
| AU (1) | AU2004290918B2 (enExample) |
| CA (2) | CA2484459A1 (enExample) |
| DE (1) | DE602004029078D1 (enExample) |
| WO (1) | WO2005049082A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071072B2 (en) * | 1999-10-08 | 2011-12-06 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| EP2783700A1 (en) * | 2006-09-07 | 2014-10-01 | Stemline Therapeutics, Inc. | Cancer stem cell-targeted cancer therapy |
| EP2526970A1 (en) * | 2006-09-07 | 2012-11-28 | Stemline Therapeutics, Inc. | Monitoring cancer stem cells |
| UY30776A1 (es) * | 2006-12-21 | 2008-07-03 | Medarex Inc | Anticuerpos cd44 |
| EP2009028A1 (en) * | 2007-06-27 | 2008-12-31 | Monoclonal Antibodies Therapeutics | Combination of a conventional anti-cancer treatment with anti-CD44 antibody administration for treating solid tumors |
| CN101368173B (zh) * | 2008-04-09 | 2011-12-28 | 协和干细胞基因工程有限公司 | 抗人cd44的工程抗体、载体、试剂盒及其用途 |
| AU2010221168A1 (en) * | 2009-03-06 | 2011-10-06 | Angstrom Pharmaceuticals, Inc. | Compositions and methods for modulation of cell migration |
| PT2531527E (pt) * | 2010-02-04 | 2014-05-16 | Hoffmann La Roche | Anticorpo monoclonal contra cd44 para ser utilizado no tratamento de carcinoma de células escamosas da cabeça e do pescoço |
| JP2014502258A (ja) * | 2010-10-22 | 2014-01-30 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | 免疫反応を抑制するためにプログラムされた制御性ｔ細胞の発見 |
| SG11201401405PA (en) * | 2011-10-26 | 2014-05-29 | Univ California | Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies |
| WO2014201417A1 (en) * | 2013-06-14 | 2014-12-18 | The University Of Kansas | Methods and compositions of modulating tumor initiating cells and the use thereof |
| NL2011904C2 (en) * | 2013-12-06 | 2015-06-09 | Stichting Vu Vumc | Leukemic stem cell markers. |
| WO2019084240A1 (en) * | 2017-10-25 | 2019-05-02 | Actinium Pharmaceuticals, Inc. | METHODS OF TREATING CANCER USING RADIO-labeled CD45 ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELLULAR THERAPIES |
| EP4103610A1 (en) * | 2020-02-13 | 2022-12-21 | UCB Biopharma SRL | Anti cd44-ctla4 bispecific antibodies |
| CN113552363B (zh) * | 2020-04-03 | 2024-03-08 | 中国科学院广州生物医药与健康研究院 | Cd44作为造血干/祖细胞的标志物及其应用 |
| EP4153192B8 (en) | 2020-05-19 | 2024-09-04 | Institut Curie | Antagonist of cd44/hyaluronic acid pathway for use in a method for the treatment of cytokine release syndrome |
| CA3220458A1 (en) | 2021-05-18 | 2022-11-24 | Janssen Biotech, Inc. | Compositions comprising a t cell redirection therapeutic and an anti-cd44 therapeutic |
| CN114213538B (zh) * | 2021-12-24 | 2022-07-08 | 北京市神经外科研究所 | Cd44抗体、嵌合抗原受体及其应用 |
| CN114316049B (zh) * | 2021-12-24 | 2022-08-09 | 北京市神经外科研究所 | Cd44抗体、嵌合抗原受体及其应用 |
| WO2024040195A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| WO2024170543A1 (en) | 2023-02-14 | 2024-08-22 | Institut National de la Santé et de la Recherche Médicale | Anti-cd44 antibodies and uses thereof |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| IL327045A (en) | 2023-10-05 | 2026-05-01 | Capstan Therapeutics Inc | Structure-restricted ionizable cationic lipids and lipid nanoparticles |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994009811A1 (en) * | 1992-10-30 | 1994-05-11 | Duke University | An adhesion molecule |
| FR2715664B1 (fr) | 1994-01-31 | 1996-04-12 | Proteine Performance Sa | Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux. |
| US6492332B1 (en) * | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
| EP0826696B1 (de) * | 1996-09-03 | 2002-05-29 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Verwendung bi-und trispezifischer Antikörper zur Induktion einer Tumorimmunität |
| JPH10301492A (ja) * | 1997-04-23 | 1998-11-13 | Sony Corp | 暗号化装置および方法、復号装置および方法、並びに情報処理装置および方法 |
| KR100653803B1 (ko) * | 2000-01-21 | 2006-12-05 | 소니 가부시끼 가이샤 | 데이터 처리 시스템 및 데이터 처리 시스템에서의 데이터 처리 방법 |
| TW538636B (en) * | 2000-09-01 | 2003-06-21 | Matsushita Electric Industrial Co Ltd | Reproduction equipment, reproduction equipment specifying equipment, reproduction equipment specifying system and methods and recording media for said equipment and system |
| US6972324B2 (en) * | 2001-05-18 | 2005-12-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antibodies specific for CD44v6 |
| DK1401869T3 (da) * | 2001-06-01 | 2008-04-28 | Biogen Idec Inc | Molekyler og fremgangsmåder til inhibering af udskillkelse af kim 1 |
-
2003
- 2003-11-19 EP EP03292873A patent/EP1532984A1/en not_active Withdrawn
-
2004
- 2004-10-08 US US10/960,699 patent/US20050147606A1/en not_active Abandoned
- 2004-10-12 CA CA002484459A patent/CA2484459A1/en not_active Abandoned
- 2004-11-19 WO PCT/EP2004/014157 patent/WO2005049082A2/en not_active Ceased
- 2004-11-19 DE DE602004029078T patent/DE602004029078D1/de not_active Expired - Lifetime
- 2004-11-19 KR KR1020067011975A patent/KR20060126659A/ko not_active Ceased
- 2004-11-19 EP EP10175623A patent/EP2275444A1/en not_active Withdrawn
- 2004-11-19 EP EP04803792A patent/EP1692183B1/en not_active Expired - Lifetime
- 2004-11-19 US US10/580,017 patent/US20070237761A1/en not_active Abandoned
- 2004-11-19 AT AT04803792T patent/ATE480565T1/de not_active IP Right Cessation
- 2004-11-19 CN CNA2004800389743A patent/CN1898268A/zh active Pending
- 2004-11-19 AU AU2004290918A patent/AU2004290918B2/en not_active Ceased
- 2004-11-19 CA CA002546566A patent/CA2546566A1/en not_active Abandoned
- 2004-11-19 JP JP2006540415A patent/JP2007513610A/ja active Pending
-
2006
- 2006-11-28 US US11/604,784 patent/US20070184051A1/en not_active Abandoned
-
2009
- 2009-03-19 US US12/407,647 patent/US20100040540A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| HK1250238A1 (zh) | 抗angptl8抗体及其用途 | |
| WO2016201450A3 (en) | Cancer treatment and diagnosis | |
| CY1120434T1 (el) | Πρωτεϊνες προσδεσης il-1 | |
| BR112012013038A2 (pt) | mutantes fc de anticorpo com funções efetoras ablacionadas | |
| EA202190248A1 (ru) | Димерные иммуномодулирующие соединения против механизмов на основе цереблона | |
| EP1990374A4 (en) | C.I. PIGMENT RED 57: 1 AND METHOD OF MANUFACTURING THEREOF | |
| EA201891435A1 (ru) | Гуманизированные моноклональные антитела, моноклональные антитела мыши или химерные моноклональные антитела против cd47 | |
| EP4628094A3 (en) | BAFF-R ANTIBODIES AND THEIR USES | |
| CY1121335T1 (el) | Anti-cxcr3 αντισωματα | |
| TW200732347A (en) | VEGF analogs and methods of use | |
| CY1113848T1 (el) | Μικροοργανισμοι για τη βελτιωση της υγειας ατομων με διαταραχες που σχετιζονται με την προσληψη γλουτενης | |
| EP2860192A3 (en) | Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38 | |
| EA201101520A1 (ru) | Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
| NO20091413L (no) | WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser | |
| EA202090031A2 (ru) | Человеческие антитела против gfr3 и способы их применения | |
| UA105760C2 (uk) | Антитіло проти bst2 | |
| NO20073175L (no) | Antigene epitoper av interleukin-21, relaterte antistoffer og anvendelse derav innen det medisinske omradet | |
| WO2016130572A3 (en) | Methods of determining levels of exposure to radiation and uses thereof | |
| DE60217698D1 (de) | Behandlung chronischer gelenkentzündung unter verwendung eines antikörpers gegen das cd3 antigenkomplex | |
| EP4524569A3 (en) | Methods, compositions and devices for treating cancer with illudofulvenes | |
| WO2007065010A3 (en) | Anti-angiogenesis compounds | |
| EA201001266A1 (ru) | Эффективные противоопухолевые парамиксовирусы | |
| CY1118918T1 (el) | Παραγοντες εξαλειψης κυτταρων β, οπως αντισωματα enanti-cd20 ή θραυσματα αυτων για την αντιμετωπιση συνδρομου χρονιας κοπωσης | |
| EA202092156A1 (ru) | Модифицированные олигонуклеотиды и способы применения в лечении таупатий |